Market Timing with TurnerTrends Provides Great Stock Picks for the Sophisticated Investor   Timing the Market well requires Stock Picks that work

TurnerTrends Stock Rating Report for ANDS

Data valid for week beginning July 21, 2008

Ticker Company Name
ANDS   [News] Anadys Pharmaceuticals Inc
Company Profile
"Anadys Pharmaceuticals, Inc., a biopharmaceutical company, engages in developing medicines in the areas of hepatitis C and oncology. It develops ANA598, a small-molecule non-nucleoside inhibitor of the NS5B polymerase for the treatment of hepatitis C- and ANA773, an oral toll-like receptor 7 agonist prodrug for cancer. The company was founded in 1992. It was formerly known as ScripTech Pharmaceuticals, Inc. and changed its name to Scriptgen Pharmaceuticals, Inc. in 1994. Later, the company changed its name to Anadys Pharmaceuticals, Inc. in 2000. Anadys Pharmaceuticals is headquartered in San Diego, California."

Join today to see our Technical, Fundamental, and Composite Stock Rating for this stock.

ANDS Technical Chart

We use technical analysis and fundamental analysis to recommend ratings for thousands of stocks. If you had a subscription, this space would show our 3 year history of trades for ANDS. However, we only show it to our subscribers.

We update our ratings and stop losses EVERY WEEK.

Don't miss out on what we recommend for Anadys Pharmaceuticals Inc next week. Sign up today and start making money!

FREE TRIAL!!


Stock Information
Friday's Close $2.90
Volume Avg. 138264 shares
Industry Biotechnology
Sector Healthcare
Our Stop Loss Members Only
Expected Move Members Only
Optionable? No

Want to take a more "hands off" approach to investing with TurnerTrends? Try our managed accounts and hedge fund at Sabinal Capital Investments
Stock Financials
Profit Margin -43.16%
Operating Margin -52.97%
Debt-to-Equity .00%
P/E ttm 0.00
EPS ttm $-0.350
EBITDA $-10,860,000
Total Revenue $23,020,000
Market Cap $67,150
Annual Dividend $.00
Yield .000%
ROE -19.11%
Revenue Growth Rate Quarterly 0.00%
Earnings Growth Rate Quarterly 0.00%
Earnings Growth Rate Yearly 0.00%
Revenue Growth Rate Average 79.84%
Earnings Growth Rate Average 0.00%
Institutional Ownership Members Only
Value Rating Members Only
TurnerTrends Score Members Only


Latest News

Mon, 7 Jul 2008 21:00:00 Etc/GMTAnadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV Call scheduled for 5:00 pm ET today (CCBN)
Mon, 7 Jul 2008 20:05:00 Etc/GMTAnadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV (PR Newswire)
Mon, 30 Jun 2008 17:09:57 Etc/GMTAnadys Pharmaceuticals, Inc. Earnings Call scheduled for Wed, July 30 (CCBN)
Fri, 6 Jun 2008 16:54:25 Etc/GMTProfits for Anadys A-Ways Off (Zacks.com)
Mon, 2 Jun 2008 20:05:00 Etc/GMTAnadys Pharmaceuticals Initiates Phase I Clinical Trial of ANA598 (PR Newswire)
Mon, 12 May 2008 22:55:00 Etc/GMTAnadys Pharmaceuticals to Present at Two Upcoming Investor Conferences (PR Newswire)
Tue, 6 May 2008 13:04:25 Etc/GMTANADYS PHARMACEUTICALS INC Financials (EDGAR Online Financials)
Thu, 1 May 2008 10:02:02 Etc/GMTANADYS PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report (EDGAR Online)
Wed, 30 Apr 2008 20:15:14 Etc/GMTANADYS PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an (EDGAR Online)
Wed, 30 Apr 2008 20:05:00 Etc/GMTAnadys Pharmaceuticals Reports First Quarter 2008 Financial Results and Highlights (PR Newswire)
Wed, 30 Apr 2008 11:08:17 Etc/GMTQ1 2008 Anadys Pharmaceuticals, Inc. Earnings Release - After Market Close (CCBN)
Wed, 5 Mar 2008 22:21:24 Etc/GMTANADYS PHARMACEUTICALS INC Files SEC form 10-K, Annual Report (EDGAR Online)
Wed, 20 Feb 2008 21:08:21 Etc/GMTANADYS PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an (EDGAR Online)
Thu, 20 Dec 2007 22:02:21 Etc/GMTANADYS PHARMACEUTICALS INC Files SEC form 8-K, Termination of a Material Definitive Agreement, Financial Statements a (EDGAR Online)
Fri, 14 Dec 2007 22:11:26 Etc/GMTANADYS PHARMACEUTICALS INC Files SEC form 8-K, Termination of a Material Definitive Agreement (EDGAR Online)
Wed, 5 Dec 2007 21:06:20 Etc/GMTANADYS PHARMACEUTICALS INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Finan (EDGAR Online)
Fri, 2 Nov 2007 10:02:02 Etc/GMTANADYS PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report (EDGAR Online)
Thu, 1 Nov 2007 20:33:30 Etc/GMTANADYS PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an (EDGAR Online)
Wed, 10 Oct 2007 10:05:03 Etc/GMTANADYS PHARMACEUTICALS INC Files SEC form 8-K, Other Events (EDGAR Online)
Wed, 29 Aug 2007 21:25:41 Etc/GMTANADYS PHARMACEUTICALS INC Files SEC form 8-K/A, Costs Associated with Exit or Disposal Activities (EDGAR Online)
News provided by Yahoo! Finance